We just received data on a new analyst forecast for $CART. Ronald Josey from Citigroup set a price target of 50.0 for CART.
To track analyst ratings and price targets for $CART, check out Quiver Quantitative's $CART forecast page.
Should you buy $CART?
Some analysts are better than others. To view the past performance of Citigroup, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CART Price Targets
Multiple analysts have issued price targets for $CART recently. We have seen 19 analysts offer price targets for $CART in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- Ronald Josey from Citigroup set a target price of $50.0 on 11/11/2025
- Bernie McTernan from Needham set a target price of $50.0 on 11/11/2025
- Mark Zgutowicz from Benchmark set a target price of $60.0 on 11/11/2025
- Brian Pitz from BMO Capital set a target price of $58.0 on 11/11/2025
- Doug Anmuth from JP Morgan set a target price of $55.0 on 11/11/2025
- Mark Kelley from Stifel set a target price of $49.0 on 10/24/2025
- John Colantuoni from Jefferies set a target price of $43.0 on 10/17/2025
$CART Congressional Stock Trading
Members of Congress have traded $CART stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CART stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 08/13 and 1 sale worth up to $15,000 on 09/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CART Insider Trading Activity
$CART insiders have traded $CART stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $CART stock by insiders over the last 6 months:
- GROSVENOR L.P. GCM has made 0 purchases and 3 sales selling 4,864,272 shares for an estimated $232,268,988.
- GROSVENOR INC. GCM has made 0 purchases and 3 sales selling 4,864,272 shares for an estimated $232,268,988.
- FIDJI SIMO has made 0 purchases and 13 sales selling 193,212 shares for an estimated $9,440,852.
- DANIEL DANKER (Chief Product Officer) has made 0 purchases and 4 sales selling 30,107 shares for an estimated $1,383,006.
- MORGAN FONG (GENERAL COUNSEL & SECRETARY) has made 0 purchases and 6 sales selling 24,673 shares for an estimated $1,095,830.
- CHRIS ROGERS (President and CEO) has made 0 purchases and 3 sales selling 18,246 shares for an estimated $803,648.
- LEVIEN MEREDITH A. KOPIT sold 4,225 shares for an estimated $200,476
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CART Hedge Fund Activity
We have seen 280 institutional investors add shares of $CART stock to their portfolio, and 202 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VIKING GLOBAL INVESTORS LP added 3,752,924 shares (+inf%) to their portfolio in Q2 2025, for an estimated $169,782,281
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 3,345,792 shares (+inf%) to their portfolio in Q2 2025, for an estimated $151,363,630
- BALYASNY ASSET MANAGEMENT L.P. removed 2,210,827 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $100,017,813
- SOUTHPOINT CAPITAL ADVISORS LP removed 2,200,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $99,528,000
- BOSTON PARTNERS added 1,911,771 shares (+93.3%) to their portfolio in Q2 2025, for an estimated $86,488,520
- SCULPTOR CAPITAL LP removed 1,671,788 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $75,631,689
- VICTORY CAPITAL MANAGEMENT INC added 1,459,235 shares (+19.8%) to their portfolio in Q2 2025, for an estimated $66,015,791
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
